CNS embryonal tumors, a formidable challenge in pediatric oncology, arise from embryonic cells within the central nervous system. Delving into their molecular underpinnings, researchers uncover intricate genetic anomalies and aberrant signaling pathways fueling their aggressive growth. With cutting-edge imaging and molecular profiling techniques, clinicians refine diagnostic precision and tailor therapeutic strategies.
Recent strides spotlight immunotherapy and targeted interventions, presenting potential breakthroughs in preclinical and clinical realms. By deciphering the intricate molecular landscapes of these tumors, the research community endeavors to forge novel treatment modalities, striving to ameliorate outcomes and enhance the lives of afflicted children.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States